Chemical biology core facility
Infrastructure and expertise for assay development, small-molecule screening and use of medicinal chemistry to optimise compounds against novel targets for 'biotool' or early drug development.
Developing new drugs and tools to understand the chemistry of life
Life is a series of chemical reactions. Chemistry powers individual cells and whole organisms, and allows them to communicate with each other. Cells have perfected the control of chemical reactions, for example by evolving various enzymes – proteins that are adapted to make specific chemical reactions occur more rapidly.
To understand more about the way life works, scientists can use chemical tools. Chemistry also allows scientists to develop new drugs that cure diseases by changing the activity of proteins or other molecules in the body.
At EMBL, chemistry is applied in various ways. The development of new chemical tools involves the design of molecules on the computer and their synthesis in the lab. These molecules can then be used to identify or tag other molecules in living cells, making it possible to observe them under the microscope. New tools also allow scientists to analyse all of a cell’s metabolites – the molecules that are produced by the chemical reactions taking place inside the cell.
To develop new drugs, several disciplines work closely together. At EMBL’s European Bioinformatics Institute (EMBL-EBI), computer programmes are developed for storing, searching, and analysing chemical data. These programmes allow scientists to predict the biological effects of specific molecules and help them to select interesting drug candidates. Engineering helps researchers by providing new technologies that enable thousands of molecules to be tested simultaneously for biological activity. Chemists can then modify these molecules further to enhance their properties. This approach can lead to the discovery of new drugs targeting common diseases, such as viral infections or cancer.
Infrastructure and expertise for assay development, small-molecule screening and use of medicinal chemistry to optimise compounds against novel targets for 'biotool' or early drug development.
The European Molecular Biology Laboratory (EMBL) is a top-ranked scientific research organization aimed to explore the secrets of life. With over 1800 employees across six European sites, EMBL integrates research groups and core facilities to foster world-class science.The Metabolomics Core Facility...
Closes on 13th October. Posted 29th September 2026
EditAbout the teamWe are seeking a skilled and highly motivated Bioinformatics Developer to join the Human Genomics Team at EMBL-EBI and contribute to the maintenance and development of the DECIPHER platform. DECIPHER is a global data sharing platform that fuels rare disease discovery and enables patien...
Closes on 9th October. Posted 17th September 2026
EditAbout the team/jobSafety and toxicology concerns remain one of the most persistent challenges in drug discovery. This is an exciting opportunity to join a multi-disciplinary team on a project to develop a comprehensive open source side effect resource for the scientific and pharmaceutical community,...
Closes on 12th October. Posted 14th September 2026
EditFrom microscopy to mycology, from development to disease modelling, EMBL researchers cover a wide range of topics in the biological sciences.